What the FDA prescribing information says The FDA-approved label for semaglutide injection (Ozempic) states: "Semaglutide causes a delay in gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications." [3] The Wegovy label repeats this language verbatim, and the tirzepatide (Mounjaro) label carries an equivalent warning [4]
Qu implicaciones tiene este hallazgo para la salud pblica
"GLP-1s can significantly reduce body weight and body fat, which could theoretically benefit athletes in sports where power-to-weight ratio, endurance efficiency, speed or weight-class requirements are important," said Dr
Alternatively, you can: Call the member services phone number on the back of your Aetna member ID card or contact Aetna by using live chat or email
Improved recognition of the condition has become increasingly important given its significant impact on quality of life, healthcare utilization, caregiver burden, and long-term disability